Skip Navigation

Osimertinib with or without platinum + pemetrexed chemotherapy in patients with locally advanced or metastatic Non-Small Cell Lung Cancer - Site Level Feasibility, FLAURA2 Phase 3

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04035486

Study #:
STUDY00145724

Start Date:
Jan 20, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04035486

View Complete Trial Details & Eligibility at ClinicalTrials.gov